UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo

Breast cancer research and treatment, 2012-04, Vol.132 (3), p.1063-1072

2012

Volltextzugriff (PDF)

Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer

NPJ breast cancer, 2023-12, Vol.9 (1), p.99-99, Article 99

2023

Volltextzugriff (PDF)

A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

JNCI : Journal of the National Cancer Institute, 2013-05, Vol.105 (10), p.701-710

2013

Volltextzugriff (PDF)

Phase II trial of the farnesyltransferase inhibitor tipifarnib plus fulvestrant in hormone receptor-positive metastatic breast cancer: New York Cancer Consortium Trial P6205

Annals of oncology, 2009-04, Vol.20 (4), p.642-647

2009

Volltextzugriff (PDF)

Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary

Annals of oncology, 2010-10, Vol.21 (10), p.2075-2080

2010

Volltextzugriff (PDF)

Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma

Annals of oncology, 2015-05, Vol.26 (5), p.958-966

2015

Volltextzugriff (PDF)

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies

Breast cancer research and treatment, 2018-06, Vol.169 (2), p.359-369

2018

Volltextzugriff (PDF)

Urinary estrogen metabolites and breast cancer: a case-control study

Cancer epidemiology, biomarkers & prevention, 1997-07, Vol.6 (7), p.505-509

1997

Volltextzugriff (PDF)

A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer

Annals of oncology, 2002-08, Vol.13 (8), p.1220-1224

2002

Volltextzugriff (PDF)

Clinical aspects and management of AIDS-related lymphoma

European journal of cancer (1990), 2001-07, Vol.37 (10), p.1296-1305

Sparano, J.A

2001

Volltextzugriff (PDF)

Doxorubicin/taxane combinations: cardiac toxicity and pharmacokinetics

Seminars in oncology, 1999-06, Vol.26 (3 Suppl 9), p.14

Sparano, J A

1999

Volltextzugriff (PDF)

Phase I Trial of Pegylated Liposomal Doxorubicin and Docetaxel in Advanced Breast Cancer

Journal of clinical oncology, 2001-06, Vol.19 (12), p.3117-3125

2001

Volltextzugriff (PDF)

Phase II Trial of Doxorubicin and Docetaxel Plus Granulocyte Colony-Stimulating Factor in Metastatic Breast Cancer: Eastern Cooperative Oncology Group Study E1196

Journal of clinical oncology, 2000-06, Vol.18 (12), p.2369-2377

2000

Volltextzugriff (PDF)

Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial

Clinical & translational oncology, 2018-11, Vol.20 (11), p.1474-1483

2018

Volltextzugriff (PDF)

Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma

Journal of clinical oncology, 1996-11, Vol.14 (11), p.3026-3035

1996

Volltextzugriff (PDF)

Use of dexrazoxane and other strategies to prevent cardiomyopathy associated with doxorubicin-taxane combinations

Seminars in oncology, 1998-08, Vol.25 (4 Suppl 10), p.66

Sparano, J A

1998

Volltextzugriff (PDF)

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

The New England journal of medicine, 2017-11, Vol.377 (19), p.1836-1846

2017

Volltextzugriff (PDF)

Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center

Journal of acquired immune deficiency syndromes (1999), 1999-08, Vol.21 Suppl 1, p.S18

1999

Volltextzugriff (PDF)

Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma

Journal of clinical oncology, 1993-10, Vol.11 (10), p.1969-1977

1993

Volltextzugriff (PDF)

Phase II Trial of Doxorubicin and Paclitaxel Plus Granulocyte Colony-Stimulating Factor in Metastatic Breast Cancer: An Eastern Cooperative Oncology Group Study

Journal of clinical oncology, 1999-12, Vol.17 (12), p.3828-3834

1999

Volltextzugriff (PDF)

Cardiac toxicity of trastuzumab (herceptin): Implications for the design of adjuvant trials

Seminars in oncology, 2001-02, Vol.28 (1D), p.20-27, Article asonc0280020d

Sparano, Joseph A.

2001

Volltextzugriff (PDF)

Phase I Trial of Escalating Doses of Paclitaxel Plus Doxorubicin and Dexrazoxane in Patients With Advanced Breast Cancer

Journal of clinical oncology, 1999-03, Vol.17 (3), p.880-886

1999

Volltextzugriff (PDF)

Opportunistic Infection and Immunologic Function in Patients With Human Immunodeficiency Virus-Associated Non-Hodgkin's Lymphoma Treated With Chemotherapy

JNCI : Journal of the National Cancer Institute, 1997-02, Vol.89 (4), p.301-307

1997

Volltextzugriff (PDF)

Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: an Eastern Cooperative Oncology Group study

Journal of clinical oncology, 1997-05, Vol.15 (5), p.1880-1884

1997

Volltextzugriff (PDF)

Compilation of phase I and II trial data of docetaxel and doxorubicin in the treatment of advanced breast cancer and other malignancies

Seminars in oncology, 1998-12, Vol.25 (6 Suppl 13), p.10-15

Sparano, J A

1998

Volltextzugriff (PDF)

1 – 25 von 462

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(443)
Mit Volltextzugriff
(394)

Publikationsform

Artikel
(460)
Bücher
(2)

Sprache

Englisch
(458)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(238)
Life Sciences & Biomedicine
(237)
Humans
(225)
Oncology
(173)
Female
(167)
Middle Aged
(135)
Adult
(120)
Biological And Medical Sciences
(112)
Medical Sciences
(110)
Aged
(106)
Male
(81)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(75)
Breast Cancer
(67)
Breast Neoplasms - Drug Therapy
(67)
Pharmacology. Drug Treatments
(63)
Breast Neoplasms - Pathology
(53)
Chemotherapy
(51)
Antineoplastic Agents
(50)
Tumors
(50)
Treatment Outcome
(45)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(96)
Cancer Research
(65)
Cancer
(19)
Seminars In Oncology
(17)
Clinical Cancer Research
(15)
Annals Of Oncology
(14)
Breast Cancer Research And Treatment
(14)
The New England Journal Of Medicine
(13)
Npj Breast Cancer
(10)
Blood
(7)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo

Optimal adjuvant therapy in older (≥70 years of age) women with low-risk early-stage breast cancer

A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

Phase II trial of the farnesyltransferase inhibitor tipifarnib plus fulvestrant in hormone receptor-positive metastatic breast cancer: New York Cancer Consortium Trial P6205

Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary

Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies

Urinary estrogen metabolites and breast cancer: a case-control study

A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer

Clinical aspects and management of AIDS-related lymphoma

Doxorubicin/taxane combinations: cardiac toxicity and pharmacokinetics

Phase I Trial of Pegylated Liposomal Doxorubicin and Docetaxel in Advanced Breast Cancer

Phase II Trial of Doxorubicin and Docetaxel Plus Granulocyte Colony-Stimulating Factor in Metastatic Breast Cancer: Eastern Cooperative Oncology Group Study E1196

Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial

Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma

Use of dexrazoxane and other strategies to prevent cardiomyopathy associated with doxorubicin-taxane combinations

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center

Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma

Phase II Trial of Doxorubicin and Paclitaxel Plus Granulocyte Colony-Stimulating Factor in Metastatic Breast Cancer: An Eastern Cooperative Oncology Group Study

Cardiac toxicity of trastuzumab (herceptin): Implications for the design of adjuvant trials

Phase I Trial of Escalating Doses of Paclitaxel Plus Doxorubicin and Dexrazoxane in Patients With Advanced Breast Cancer

Opportunistic Infection and Immunologic Function in Patients With Human Immunodeficiency Virus-Associated Non-Hodgkin's Lymphoma Treated With Chemotherapy

Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: an Eastern Cooperative Oncology Group study

Compilation of phase I and II trial data of docetaxel and doxorubicin in the treatment of advanced breast cancer and other malignancies

Suchergebnisse filtern